Eli Lilly Director Juan R. Luciano Receives Deferred Stock Units
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filing: ELI LILLY & Co ($LLY) Insider: LUCIANO JUAN R (Director) Action: Acquired 12.83 shares @ $1,240.34 (Value: ~$15,917) Ownership After: 16,969.65 shares Significance: Low (Deferred director compensation)
Comprehensive Analysis
Overview
On October 20, 2026, Eli Lilly & Co ($LLY) filed a Form 4 detailing an equity acquisition by Director Juan R. Luciano.
Transaction Details
- Transaction Date: October 19, 2026
- Nature of Transaction: Grant/Award (Transaction Code
A) - Shares Acquired: 12.8325 shares
- Price Per Share: $1,240.34
- Gross Value: ~$15,916.66
- Post-Transaction Holdings: 16,969.6463 shares (Direct)
Footnote & Context
According to the filing, the shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan. These units will settle in common shares following Mr. Luciano's departure from the board.
Market Significance
This transaction reflects routine director compensation deferral rather than an open-market purchase or sale. Because the transaction size is modest (~$15.9k) and executed automatically per plan rules, it holds low trading significance for investors.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.